[Fu'an Pharmaceutical: Subsidiary received the drug registration certificate for lysine for injection] On September 11, Fu'an Pharmaceutical (300194.SZ) announced that the company's wholly-owned subsidiary Qingyutang Pharmaceutical recently received the drug registration certificate for lysine for injection issued by the State Food and Drug Administration. The registration classification is Class 3 chemical drugs, and the specifications include 0.5g and 0.9g. This medicine is suitable for the treatment of fever and moderate pain that are not suitable for oral administration. Up to now, a total of 11 companies (including Qingyutang) have passed or are deemed to have passed the consistency evaluation of this drug. The company stated that obtaining the registration certificate this time will further enrich the subsidiary's product line and enhance market competitiveness. However, due to the influence of industry policies and market environment, there are uncertainties in product production and sales and the specific impact on performance.